Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates
Liao, John B, Gwin, William R, Urban, Renata R, Hitchcock-Bernhardt, Katie M, Coveler, Andrew L, Higgins, Doreen M, Childs, Jennifer S, Shakalia, Hania N, Swensen, Ron E, Stanton, Sasha E, Tinker, Anna V, Wahl, Tanya A, Ancheta, Richard G, McGonigle, Kathryn F, Dai, James Y, Disis, Mary L, Goff, Barbara A
Published in Journal for immunotherapy of cancer (01.09.2021)
Published in Journal for immunotherapy of cancer (01.09.2021)
Get full text
Journal Article
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2
Ganz, Patricia A, Romond, Edward H, Cecchini, Reena S, Rastogi, Priya, Geyer, Jr, Charles E, Swain, Sandra M, Jeong, Jong-Hyeon, Fehrenbacher, Louis, Gross, Howard M, Brufsky, Adam M, Flynn, Patrick J, Wahl, Tanya A, Seay, Thomas E, Wade, 3rd, James L, Biggs, David D, Atkins, James N, Polikoff, Jonathan, Zapas, John L, Mamounas, Eleftherios P, Wolmark, Norman
Published in Journal of clinical oncology (10.12.2017)
Published in Journal of clinical oncology (10.12.2017)
Get full text
Journal Article
Management of adverse events in patients with HER2+ metastatic breast cancer treated with tucatinib, trastuzumab, and capecitabine (HER2CLIMB)
Okines, Alicia Frances Clare, Paplomata, Elisavet, Wahl, Tanya A., Wright, Gail Lynn Shaw, Sutherland, Stephanie, Jakobsen, Erik, Valdes, Frances, Chan, Arlene, Clark, Amy Sanders, Conlin, Alison Katherine, Lustberg, Maryam B., Specht, Jennifer M., Pluard, Timothy J., Zhu, Xiaofu, Krop, Ian E., Gelmon, Karen A., Slamon, Dennis J., Ramos, Jorge, An, Grace, Hamilton, Erika Paige
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Patient-reported outcomes (PROs) from KATHERINE: A phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer
Schneeweiss, Andreas, Loibl, Sibylle, Mamounas, Eleftherios P., Minckwitz, Gunter von, Mano, Max S., Untch, Michael, Huang, Chiun-Sheng, Rastogi, Priya, Conte, Pier Franco, D'hondt, Veronique, Redondo, Andres, Stamatovic, Ljiljana, Bonnefoi, Herve R., Castro Salguero, Hugo Raul, Fischer, Hans Holger, Wahl, Tanya A., Song, Chunyan, Blotner, Steven, Trask, Peter, Geyer, Charles E.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Pembrolizumab with low dose carboplatin for recurrent platinum resistant ovarian, fallopian tube, and primary peritoneal cancer-interim results
Liao, John B., Gwin, William Rayford, Urban, Renata, Hitchcock-Bernhardt, Katie, Coveler, Andrew L., Higgins, Doreen, Childs, Jennifer S, Shakalia, Hania, Stanton, Sasha E., Tinker, Anna, Wahl, Tanya A., Ancheta, Richard G., McGonigle, Kathryn F., Dai, James, Disis, Mary L., Goff, Barbara Ann
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Analysis of reimbursement (R) for next generation sequencing (NGS) on patients' tumors in the context of a personalized medicine program
Brown, Thomas D., Tameishi, Mariko, Liu, Xiaoyu, Scanlan, James, Beatty, J. David, Drescher, Charles, Pagel, John M., Gold, Philip Jordan, Alexander, Shlece, Summers, Lauren K., Brindle, Madeleine, Varghis, Nina, Yates, James, Fondren, Kathleen N., Birchfield, George Richard, Dong, David Edwin, Benkers, Tara L., Wahl, Tanya A., Ramsey, Scott David, Berry, Anna Belinda
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
A phase Ib/II trial with expansion of patients at the MTD trial of olaparib plus weekly (metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients
Rivkin, Saul E., Iriarte, Desiree, Sloan, Heather, Wiseman, Cara, Moon, James, Goodman, Gary E., Bondurant, Amy, Veljovich, Daniel, Jiang, Peter Y. Z., Wahl, Tanya A., Shah, Chirag, Drescher, Charles, Kaplan, Henry G., Peters, William A., Ellis, Erin, Fer, Mehmet F., Park, Min S., Johnston, Eileen
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article